Detection of Host-Derived Sphingosine by Pseudomonas aeruginosa Is Important for Survival in the Murine Lung

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  LaBauve, Annette E ^a   Wargo, Matthew J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; SPHINGOSINE; TRANSCRIPTION FACTOR;

ANIMAL; BACTERIAL PNEUMONIA; GENE DELETION; GENETICS; HUMAN; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANIMALS; BACTERIAL PROTEINS; GENE DELETION; HUMANS; LUNG; MICE; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPHINGOSINE; TRANSCRIPTION FACTORS;

EID: 84893787410     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003889     Document Type: Article

References (76)

1. Lieberman D, Lieberman D, (2003) Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med 2: 459-468.
2. Chastre J, Fagon JY, (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165: 867-903.
3. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr, (1996) Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109: 1019-1029.
4. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, et al. (1998) Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27: 158-163.
5. Briesacher BA, Quittner AL, Fouayzi H, Zhang J, Swensen A, (2011) Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007. Pediatr Pulmonol 46: 770-776.
6. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, et al. (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183: 444-452.
7. Rajan S, Saiman L, (2002) Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17: 47-56.
8. Butorac-Petanjek B, Parnham MJ, Popovic-Grle S, (2010) Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemother 22: 291-297.
9. Klockgether J, Munder A, Neugebauer J, Davenport CF, Stanke F, et al. (2010) Genome diversity of Pseudomonas aeruginosa PAO1 laboratory strains. J Bacteriol 192: 1113-1121.
10. Fischbach MA, Walsh CT, (2009) Antibiotics for emerging pathogens. Science 325: 1089-1093.
11. Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, et al. (2004) Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun 72: 5433-5438.
12. Palmer KL, Mashburn LM, Singh PK, Whiteley M, (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267-5277.
13. Chroneos ZC, Sever-Chroneos Z, Shepherd VL, (2010) Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem 25: 13-26.
14. Glasser JR, Mallampalli RK, (2012) Surfactant and its role in the pathobiology of pulmonary infection. Microbes Infect 14: 17-25.
15. Caminiti SP, Young SL, (1991) The pulmonary surfactant system. Hosp Pract (Off Ed) 26: 87-90, 94-100.
16. Hannun YA, Obeid LM, (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
17. Spiegel S, Milstien S, (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11: 403-415.
18. Ohanian J, Ohanian V, (2001) Sphingolipids in mammalian cell signalling. Cell Mol Life Sci 58: 2053-2068.
19. van Meer G, Voelker DR, Feigenson GW, (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112-124.
20. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, et al. (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309: 1735-1739.
21. Vogel P, Donoviel MS, Read R, Hansen GM, Hazlewood J, et al. (2009) Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 4: e4112.
22. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, et al. (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 8: 1337-1344.
23. Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, et al. (1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274: 35343-35350.
24. Postma FR, Jalink K, Hengeveld T, Moolenaar WH, (1996) Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J 15: 2388-2392.
25. Roviezzo F, Brancaleone V, De Gruttola L, Vellecco V, Bucci M, et al. (2011) Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. J Pharmacol Exp Ther 337: 830-837.
26. Hammad SM, (2011) Blood sphingolipids in homeostasis and pathobiology. Adv Exp Med Biol 721: 57-66.
27. Oskeritzian CA, Price MM, Hait NC, Kapitonov D, Falanga YT, et al. (2010) Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med 207: 465-474.
28. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, et al. (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 119: 1871-1879.
29. Jackson AA, Gross MJ, Daniels EF, Hampton TH, Hammond JH, et al. (2013) Anr and Its Activation by PlcH Activity in Pseudomonas aeruginosa Host Colonization and Virulence. J Bacteriol 195: 3093-3104.
30. Wargo MJ, Szwergold BS, Hogan DA, (2008) Identification of two gene clusters and a transcriptional regulator required for Pseudomonas aeruginosa glycine betaine catabolism. J Bacteriol 190: 2690-2699.
31. Wargo MJ, Ho TC, Gross MJ, Whittaker LA, Hogan DA, (2009) GbdR regulates Pseudomonas aeruginosa plcH and pchP transcription in response to choline catabolites. Infect Immun 77: 1103-1111.
32. Hampel KJ, Labauve AE, Meadows JA, Fitzsimmons LF, Nock AM, et al. (2013) Characterization of the GbdR regulon in Pseudomonas aeruginosa. J Bacteriol 196: 7-15.
33. Nelson GJ, (1967) Studies on the lipids of sheep red blood cells. I. Lipid composition in low and high potassium red cells. Lipids 2: 64-71.
34. Lengle E, Geyer RP, (1972) Comparison of cellular lipids of serum-free strain L mouse fibroblasts. Biochim Biophys Acta 260: 608-616.
35. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, et al. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 121: 969-973.
36. Law SLS, Squier CA, Wertz PW, (1994) Free Sphingosine in Oral Epithelium. Journal of Dental Research 73: 108-108.
37. Okino N, Tani M, Imayama S, Ito M, (1998) Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa. J Biol Chem 273: 14368-14373.
38. Lassmann T, Sonnhammer EL, (2005) Kalign-an accurate and fast multiple sequence alignment algorithm. BMC Bioinformatics 6: 298.
39. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, et al. (2011) Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39: D596-600.
40. Lucchesi GI, Lisa TA, Domenech CE, (1989) Choline and betaine as inducer agents of Pseudomonas aeruginosa phospholipase C activity in high phosphate medium. FEMS Microbiol Lett 48: 335-338.
41. Sage AE, Vasil AI, Vasil ML, (1997) Molecular characterization of mutants affected in the osmoprotectant-dependent induction of phospholipase C in Pseudomonas aeruginosa PAO1. Mol Microbiol 23: 43-56.
42. Sage AE, Vasil ML, (1997) Osmoprotectant-dependent expression of plcH, encoding the hemolytic phospholipase C, is subject to novel catabolite repression control in Pseudomonas aeruginosa PAO1. J Bacteriol 179: 4874-4881.
43. Shortridge VD, Lazdunski A, Vasil ML, (1992) Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa. Mol Microbiol 6: 863-871.
44. Wargo MJ, Hogan DA, (2009) Identification of genes required for Pseudomonas aeruginosa carnitine catabolism. Microbiology 155: 2411-2419.
45. Fischer CL, Drake D, Dawson DV, Blanchette DR, Brogden KA, et al. (2012) Antibacterial activity of sphingoid bases and fatty acids against gram-positive bacteria and gram-negative bacteria. Antimicrob Agents Chemother 56: 1157-1161 Epub ahead of print.
46. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, et al. (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14: 382-391.
47. Park K, Elias PM, Shin KO, Lee YM, Hupe M, et al. (2013) A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. Mol Cell Biol 33: 752-762.
48. Garg SK, Volpe E, Palmieri G, Mattei M, Galati D, et al. (2004) Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. J Infect Dis 189: 2129-2138.
49. Malik ZA, Thompson CR, Hashimi S, Porter B, Iyer SS, et al. (2003) Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J Immunol 170: 2811-2815.
50. Garg SK, Santucci MB, Panitti M, Pucillo L, Bocchino M, et al. (2006) Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? Clin Immunol 121: 260-264.
51. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C, (1999) Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34: 257-267.
52. Recchi C, Sclavi B, Rauzier J, Gicquel B, Reyrat JM, (2003) Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulation. J Biol Chem 278: 33763-33773.
53. Gallegos MT, Schleif R, Bairoch A, Hofmann K, Ramos JL, (1997) Arac/XylS family of transcriptional regulators. Microbiol Mol Biol Rev 61: 393-410.
54. Okino N, Ito M, (2007) Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa. J Biol Chem 282: 6021-6030.
55. Chatterjee A, Dutta PK, Chowdhury R, (2007) Effect of fatty acids and cholesterol present in bile on expression of virulence factors and motility of Vibrio cholerae. Infect Immun 75: 1946-1953.
56. Lowden MJ, Skorupski K, Pellegrini M, Chiorazzo MG, Taylor RK, et al. (2010) Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes. Proc Natl Acad Sci U S A 107: 2860-2865.
57. Luberto C, Stonehouse MJ, Collins EA, Marchesini N, El-Bawab S, et al. (2003) Purification, characterization, and identification of a sphingomyelin synthase from Pseudomonas aeruginosa. PlcH is a multifunctional enzyme. J Biol Chem 278: 32733-32743.
58. Ricketts CRSJ, Topley E, Lilly HA, (1951) Human skin lipids with particular reference to the self-sterilising power of the skin. Clinical Science 10: 89-111.
59. Wertz PW, Downing DT, (1990) Free sphingosine in human epidermis. J Invest Dermatol 94: 159-161.
60. Bibel DJ, Aly R, Shah S, Shinefield HR, (1993) Sphingosines: antimicrobial barriers of the skin. Acta Derm Venereol 73: 407-411.
61. Bibel DJ, Aly R, Shinefield HR, (1992) Antimicrobial activity of sphingosines. J Invest Dermatol 98: 269-273.
62. Fischer CL, Drake DR, Dawson DV, Blanchette DR, Brogden KA, et al. (2012) Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 56: 1157-1161.
63. Fischer CL, Walters KS, Drake DR, Blanchette DR, Dawson DV, et al. (2013) Sphingoid Bases Are Taken Up by Escherichia coli and Staphylococcus aureus and Induce Ultrastructural Damage. Skin Pharmacol Physiol 26: 36-44.
64. Kelley LA, Sternberg MJ, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363-371.
65. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, et al. (2003) In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5: 1294-1308.
66. Neidhardt FC, Bloch PL, Smith DF, (1974) Culture medium for enterobacteria. J Bacteriol 119: 736-747.
67. LaBauve AE, Wargo MJ, (2012) Growth and laboratory maintenance of Pseudomonas aeruginosa. Curr Protoc Microbiol Chapter 6: Unit 6E 1.
68. Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, et al. (2011) Hemolytic Phospholipase C Inhibition Protects Lung Function During Pseudomonas aeruginosa Infection. Am J Respir Crit Care Med 184: 345-354.
69. Wargo MJ, (2013) Choline Catabolism to Glycine Betaine Contributes to Pseudomonas aeruginosa Survival during Murine Lung Infection. PLoS One 8: e56850.
70. Shanks RM, Caiazza NC, Hinsa SM, Toutain CM, O'Toole GA, (2006) Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol 72: 5027-5036.
71. Choi KH, Schweizer HP, (2006) mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat Protoc 1: 153-161.
72. Fitzsimmons LF, Hampel KJ, Wargo MJ, (2012) Cellular choline and glycine betaine pools impact osmoprotection and phospholipase C production in Pseudomonas aeruginosa. J Bacteriol 194: 4718-4726.
73. Miller JH (1972) Experiments in molecular genetics. Cold Spring, NY: Cold Spring Harbor Laboratory.
74. Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, et al. (2012) The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog 8: e1002945.
75. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 14339-14344.
76. Simon R, Priefer U, Puhler A, (1983) A Broad Host Range Mobilization System for Invivo Genetic-Engineering- Transposon Mutagenesis in Gram-Negative Bacteria. Bio-Technology 1: 784-791.